期刊
JOURNAL OF NATURAL PRODUCTS
卷 74, 期 5, 页码 1003-1008出版社
AMER CHEMICAL SOC
DOI: 10.1021/np100877h
关键词
-
资金
- Division of Cancer Treatment and Diagnosis, NCI, DHHS [RO1 CA 90441-02-05, 2R56-CA 090441-06A1, 5R01 CA 090441-07]
- Arizona Disease Control Research Commission
- J. W. Kieckhefer Foundation
- Margaret T. Morris Foundation
- Robert B. Dalton Endowment Fund
Three advances necessary to bring dolastatin 16 (1) into full-scale preclinical development as an anticancer drug have been accomplished. The X-ray crystal structure of dolastatin 16 has been solved, which allowed stereoselective syntheses of its two new amino acid units, dolamethylleuine (Dml) and dolaphenvaline (Dpv), to be completed. The X-ray crystal structures of synthetic Z-Dml and TFA-Dpv have also been completed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据